SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 or 15d-16
UNDER THE SECURITIES EXCHANGE ACT of 1934
For the Month of March 2022
(Commission File Number)
P.V NANO CELL LTD.
(Translation of registrant’s name into English)
8 Hamasger Street
Migdal Ha’Emek, 2310102, Israel
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(l): _________
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): _________
P.V. Nano Cell Ltd. (the “Company”) hereby furnishes the following documents:
|i.||Notice and Proxy Statement with respect to the Company’s special general meeting of the shareholders to be held on April 7, 2022|
|ii.||Proxy Card to be used with respect to the Company’s special l general meeting of the shareolders to be held on April 7, 2022|
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|Date: March 23, 2022||P.V NANO CELL LTD.|
|By:||/s/ Evyatar Cohen|
|Title:||Chief Financial Officer|